• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 8, 2007

View Archived Issues

Sunitinib safe and active in phase II hepatocellular carcinoma study

Read More

Phase I trial compares daily, twice daily ARRY-543 in patients with solid tumors

Read More

Safety demonstrated by RTS,S/AS02D malaria vaccine encourages phase III study

Read More

FDA grants a second orphan drug designation to Thrombotargets for TT-103MH

Read More

Human Genome Sciences completes enrollment in ACHIEVE 2/3 phase III trial of Albuferon

Read More

The National Institutes of Health awards Progenics with grants totaling USD 1.9 million

Read More

Phase III mifamurtide data confirms superior overall survival in osteosarcoma

Read More

huC242-DM4: preclinical studies and a phase I trial

Read More

MEDI-528 well tolerated to date in phase II asthma trial

Read More

Analyses highlight efficacy of ambrisentan in pulmonary arterial hypertension

Read More

Dynavax and Merck & Co. enter global license agreement to jointly develop Heplisav

Read More

CV Therapeutics reports positive data from phase I study of CVT-6883

Read More

European AIDS Conference: Studies of atazanavir/ritonavir

Read More

Agents for arthritis and other inflammatory disorders disclosed in recent patents

Read More

Recent patents cover new therapeutic agents for cancer

Read More

FDA approves Epeius's phase II registration protocol of Rexin-G for osteosarcoma

Read More

Immtech completes trial of pafuramidine for prevention of malaria

Read More

FDA extends action date for priority review of Regeneron's BLA for rilonacept

Read More

Takeda's TAK-442 enters into phase II clinical stage for venous/arterial thromboembolism

Read More

Insmed initiates phase II clinical trial of Iplex for myotonic muscular dystrophy

Read More

Gentium seeks amendment to phase III trial of defibrotide for hepatic veno-occlusive disease

Read More

Generex administers first dose in phase I clinical trial of AE-37 vaccine peptide

Read More

Vectura reports positive data from second phase II clinical study of VR-040

Read More

GeoVax reports positive data from full-dose phase I HIV/AIDS vaccine human trial

Read More

Recent Allergan patent describes novel antiglaucoma agents

Read More

Gilead and LG Life Sciences enter license agreement to develop caspase inhibitors

Read More

Merck Serono submits MAA for sapropterin in the treatment of HPA

Read More

Preclinical profile of a novel triple reuptake inhibitor from Roche

Read More

V1b receptor antagonist Org-52186 reduces stress-induced HPA axis hyperactivity

Read More

nAChR alpha7 full agonist with procognitive and neuroprotective properties

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 2, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 2, 2025.
  • Molecule illustration

    Unnatural Products joins Argenx in a $1.5B macrocyclic deal

    BioWorld
    Unnatural Products Inc. notched another collaboration by signing on with Argenx SE in a multitarget research collaboration. Unnatural Products, which is getting...
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • CMS logo and website

    CMS eyes competitive bidding for CGMs, insulin pumps

    BioWorld MedTech
    The U.S. Centers for Medicare & Medicaid Services posted the draft home health rule for calendar year 2026, which includes a proposal to subject continuous...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe